The Impact of COVID-19 Pandemic on ESBL-Producing Enterobacterales Infections: A Scoping Review
Antibiotics · 16.06.2023 · 12 (6) · 1064
DOI: 10.3390/antibiotics12061064 ↗Kurz gefasst
Scoping Review in der Zeitschrift Antibiotics, online erschienen am 16.06.2023. Verfasst von Ha Thi Thao Mai und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Medicine, Can Tho University of Medicine and Pharmacy, Can Tho City 900000, Vietnam. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Several studies have reported an increased frequency of colonization and/or infection with antibiotic-resistant bacteria (ARB) during the COVID-19 pandemic. Extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-PE) are a group of bacteria with intrinsic resistance to multiple antibiotics, including penicillins, cephalosporins, and monobactams. These pathogens are easy to spread and can cause difficult-to-treat infections. Here, we summarize the available evidence on the impact of the COVID-19 pandemic on infections caused by ESBL-PE. Using specific criteria and keywords, we searched PubMed, MEDLINE, and EMBASE for articles published up to 30 March 2023 on potential changes in the epidemiology of ESBL-E since the beginning of the COVID-19 pandemic. We identified eight studies that documented the impact of COVID-19 on ESBL-E. Five studies were focused on assessing the frequency of ESBL-PE in patient-derived specimens, and three studies investigated the epidemiological aspects of ESBL-PE infections in the context of the COVID-19 pandemic. Some of the studies that were focused on patient specimens reported a decrease in ESBL-PE positivity during the pandemic, whereas the three studies that involved patient data (1829 patients in total) reported a higher incidence of ESBL-PE infections in patients hospitalized for COVID-19 compared with those with other conditions. There are limited data on the real impact of the COVID-19 pandemic on the epidemiology of ESBL-PE infections; however, patient-derived data suggest that the pandemic has exacerbated the spread of these pathogens.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Medicine, Can Tho University of Medicine and Pharmacy, Can Tho City 900000, Vietnam.
- Faculty of Health Sciences, Kanazawa University, Kanazawa 920-0942, Ishikawa, Japan.
ORCID-Profile: Ha Thi Thao Mai, J Luis Espinoza
Zitieren
APA
Mai, H. T. T., & Espinoza, J. L. (2023). The Impact of COVID-19 Pandemic on ESBL-Producing Enterobacterales Infections: A Scoping Review. Antibiotics, 12(6), 1064. https://doi.org/10.3390/antibiotics12061064
Vancouver
Mai HTT, Espinoza JL. The Impact of COVID-19 Pandemic on ESBL-Producing Enterobacterales Infections: A Scoping Review. Antibiotics. 2023;12(6):1064. doi:10.3390/antibiotics12061064
BibTeX
@article{Mai2023,
author = {Mai, Ha Thi Thao and Espinoza, J Luis},
title = {The Impact of COVID-19 Pandemic on ESBL-Producing Enterobacterales Infections: A Scoping Review},
journal = {Antibiotics},
year = {2023},
volume = {12},
number = {6},
pages = {1064},
doi = {10.3390/antibiotics12061064}
}
EUVIMED